197 related articles for article (PubMed ID: 37354000)
1. The distribution and accumulation of the shortest telomeres in telomere biology disorders.
Raj HA; Lai TP; Niewisch MR; Giri N; Wang Y; Spellman SR; Aviv A; Gadalla SM; Savage SA
Br J Haematol; 2023 Dec; 203(5):820-828. PubMed ID: 37354000
[TBL] [Abstract][Full Text] [Related]
2. Buildup from birth onward of short telomeres in human hematopoietic cells.
Lai TP; Verhulst S; Savage SA; Gadalla SM; Benetos A; Toupance S; Factor-Litvak P; Susser E; Aviv A
Aging Cell; 2023 Jun; 22(6):e13844. PubMed ID: 37118904
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.
Agarwal S
Hematol Oncol Clin North Am; 2018 Aug; 32(4):669-685. PubMed ID: 30047419
[TBL] [Abstract][Full Text] [Related]
4. Dyskeratosis congenita and telomere biology disorders.
Savage SA
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):637-648. PubMed ID: 36485133
[TBL] [Abstract][Full Text] [Related]
5. Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita.
Beier F; Foronda M; Martinez P; Blasco MA
Blood; 2012 Oct; 120(15):2990-3000. PubMed ID: 22932806
[TBL] [Abstract][Full Text] [Related]
6. Disease progression and clinical outcomes in telomere biology disorders.
Niewisch MR; Giri N; McReynolds LJ; Alsaggaf R; Bhala S; Alter BP; Savage SA
Blood; 2022 Mar; 139(12):1807-1819. PubMed ID: 34852175
[TBL] [Abstract][Full Text] [Related]
7. An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.
Niewisch MR; Savage SA
Expert Rev Hematol; 2019 Dec; 12(12):1037-1052. PubMed ID: 31478401
[No Abstract] [Full Text] [Related]
8. Telomere length in inherited bone marrow failure syndromes.
Alter BP; Giri N; Savage SA; Rosenberg PS
Haematologica; 2015 Jan; 100(1):49-54. PubMed ID: 25304614
[TBL] [Abstract][Full Text] [Related]
9. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita.
Alter BP; Rosenberg PS; Giri N; Baerlocher GM; Lansdorp PM; Savage SA
Haematologica; 2012 Mar; 97(3):353-9. PubMed ID: 22058220
[TBL] [Abstract][Full Text] [Related]
10. Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita.
Khincha PP; Bertuch AA; Gadalla SM; Giri N; Alter BP; Savage SA
Blood Adv; 2018 Jun; 2(11):1243-1249. PubMed ID: 29853525
[TBL] [Abstract][Full Text] [Related]
11. The Nexus Between Telomere Length and Lymphocyte Count in Seniors Hospitalized With COVID-19.
Benetos A; Lai TP; Toupance S; Labat C; Verhulst S; Gautier S; Ungeheuer MN; Perret-Guillaume C; Levy D; Susser E; Aviv A
J Gerontol A Biol Sci Med Sci; 2021 Jul; 76(8):e97-e101. PubMed ID: 33528568
[TBL] [Abstract][Full Text] [Related]
12. Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes.
Gadalla SM; Cawthon R; Giri N; Alter BP; Savage SA
Aging (Albany NY); 2010 Nov; 2(11):867-74. PubMed ID: 21113082
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders.
Balakumaran A; Mishra PJ; Pawelczyk E; Yoshizawa S; Sworder BJ; Cherman N; Kuznetsov SA; Bianco P; Giri N; Savage SA; Merlino G; Dumitriu B; Dunbar CE; Young NS; Alter BP; Robey PG
Blood; 2015 Jan; 125(5):793-802. PubMed ID: 25499762
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Leukocyte Telomere Length Measurement Methods in Patients with Dyskeratosis Congenita and in Their Unaffected Relatives.
Khincha PP; Dagnall CL; Hicks B; Jones K; Aviv A; Kimura M; Katki H; Aubert G; Giri N; Alter BP; Savage SA; Gadalla SM
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28805708
[TBL] [Abstract][Full Text] [Related]
15. Comparison of telomere length in patients with bone marrow failure syndromes and healthy controls.
Barade A; Lakshmi KM; Korula A; Abubacker FN; Kulkarni UP; Abraham A; Mathews V; George B; Edison ES
Eur J Haematol; 2024 May; 112(5):810-818. PubMed ID: 38213291
[TBL] [Abstract][Full Text] [Related]
16. The relationship between DNA methylation and telomere length in dyskeratosis congenita.
Gadalla SM; Katki HA; Shebl FM; Giri N; Alter BP; Savage SA
Aging Cell; 2012 Feb; 11(1):24-8. PubMed ID: 21981348
[TBL] [Abstract][Full Text] [Related]
17. The role of telomere biology in bone marrow failure and other disorders.
Savage SA; Alter BP
Mech Ageing Dev; 2008; 129(1-2):35-47. PubMed ID: 18160098
[TBL] [Abstract][Full Text] [Related]
18. Telomere shortening in human diseases.
Kong CM; Lee XW; Wang X
FEBS J; 2013 Jul; 280(14):3180-93. PubMed ID: 23647631
[TBL] [Abstract][Full Text] [Related]
19. Impaired reproductive function and fertility preservation in a woman with a dyskeratosis congenita.
Robinson LG; Pimentel R; Wang F; Kramer YG; Gonullu DC; Agarwal S; Navarro PA; McCulloh D; Keefe DL
J Assist Reprod Genet; 2020 May; 37(5):1221-1225. PubMed ID: 32405899
[TBL] [Abstract][Full Text] [Related]
20. Transient elastography in adult patients with cryptic dyskeratosis congenita reveals subclinical liver fibrosis: a retrospective analysis of the Aachen telomere biology disease registry.
Tometten M; Kirschner M; Isfort S; Berres ML; Brümmendorf TH; Beier F
Orphanet J Rare Dis; 2021 Sep; 16(1):395. PubMed ID: 34565437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
